Triazole-derivative antiepileptic
Rufinamide
Brand names: Inovelon
Adult dose
Dose: Initial 400mg PO BD (with food), increase by 400mg/day every 2 days; max 3.2g/day
Route: PO
Frequency: BD
Clinical pearls
- Lennox-Gastaut syndrome (≥1 year) as adjunct
- Take with food
Contraindications
- Familial short QT syndrome
- Severe hepatic impairment
- Hypersensitivity
Side effects
- Drowsiness
- Headache
- Dizziness
- Shortened QT interval
- Hypersensitivity syndrome (DRESS)
- Suicidal ideation
Interactions
- Valproate (raises rufinamide)
- Carbamazepine/phenytoin (lower)
- Hormonal contraceptives (reduces efficacy)
Monitoring
- ECG
- Symptoms
- Mood
Reference: BNF; NICE NG217; https://bnf.nice.org.uk/drugs/rufinamide/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS